• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产KPC肺炎克雷伯菌中质粒携带的柠檬酸铁转运系统赋予的头孢地尔耐药性

Cefiderocol Resistance Conferred by Plasmid-Located Ferric Citrate Transport System in KPC-Producing Klebsiella pneumoniae.

作者信息

Polani Riccardo, De Francesco Alice, Tomolillo Dario, Artuso Irene, Equestre Michele, Trirocco Rita, Arcari Gabriele, Antonelli Guido, Villa Laura, Prosseda Gianni, Visca Paolo, Carattoli Alessandra

出版信息

Emerg Infect Dis. 2025 Jan;31(1):123-124. doi: 10.3201/eid3101.241426.

DOI:10.3201/eid3101.241426
PMID:39714320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11682805/
Abstract

Cefiderocol (FDC), a siderophore-cephalosporin conjugate, is the newest option for treating infection with carbapenem-resistant gram-negative bacteria. We identified a novel mechanism contributing to decreased FDC susceptibility in Klebsiella pneumoniae clinical isolates. The mechanism involves 2 coresident plasmids: pKpQIL, carrying variants of bla carbapenemase gene, and pKPN, carrying the ferric citrate transport (FEC) system. We observed increasing FDC MICs in an Escherichia coli model system carrying different natural pKpQIL plasmids, encoding different K. pneumoniae carbapenemase (KPC) variants, in combination with a conjugative low copy number vector carrying the fec gene cluster from pKPN. We observed transcriptional repression of fiu, cirA, fepA, and fhuA siderophore receptor genes in bla-fec-E. coli cells treated with ferric citrate. Screening of 27,793 K. pneumoniae whole-genome sequences revealed that the fec cluster occurs frequently in some globally distributed different KPC-producing K. pneumoniae clones (sequence types 258, 14, 45, and 512), contributing to reduced FDC susceptibility.

摘要

头孢地尔(FDC)是一种铁载体-头孢菌素缀合物,是治疗耐碳青霉烯革兰氏阴性菌感染的最新选择。我们发现了一种导致肺炎克雷伯菌临床分离株对FDC敏感性降低的新机制。该机制涉及两个共存质粒:携带碳青霉烯酶基因变体的pKpQIL和携带柠檬酸铁转运(FEC)系统的pKPN。我们在携带不同天然pKpQIL质粒(编码不同的肺炎克雷伯菌碳青霉烯酶(KPC)变体)的大肠杆菌模型系统中观察到FDC最低抑菌浓度(MIC)增加,该系统与携带来自pKPN的fec基因簇的接合型低拷贝数载体结合。我们观察到在用柠檬酸铁处理的bla-fec-大肠杆菌细胞中,fiu、cirA、fepA和fhuA铁载体受体基因的转录受到抑制。对27793个肺炎克雷伯菌全基因组序列的筛选显示,fec簇在一些全球分布的不同产KPC肺炎克雷伯菌克隆(序列类型258、14、45和512)中频繁出现,导致对FDC的敏感性降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/dcf0fe2d7797/24-1426-F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/28484713e6da/24-1426-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/aebd1d1c0997/24-1426-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/6b0ccefd7e3e/24-1426-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/f9d693ef6c8b/24-1426-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/c841e8b85cb2/24-1426-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/4cdf0267bbc4/24-1426-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/dcf0fe2d7797/24-1426-F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/28484713e6da/24-1426-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/aebd1d1c0997/24-1426-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/6b0ccefd7e3e/24-1426-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/f9d693ef6c8b/24-1426-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/c841e8b85cb2/24-1426-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/4cdf0267bbc4/24-1426-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/11682805/dcf0fe2d7797/24-1426-F7.jpg

相似文献

1
Cefiderocol Resistance Conferred by Plasmid-Located Ferric Citrate Transport System in KPC-Producing Klebsiella pneumoniae.产KPC肺炎克雷伯菌中质粒携带的柠檬酸铁转运系统赋予的头孢地尔耐药性
Emerg Infect Dis. 2025 Jan;31(1):123-124. doi: 10.3201/eid3101.241426.
2
Overexpression of β-lactamase genes ( ) and novel CirA deficiencies contribute to decreased cefiderocol susceptibility in carbapenem-resistant before its approval in China.β-内酰胺酶基因()过表达和新型 CirA 缺失导致碳青霉烯类耐药肠杆菌科细菌对头孢地尔的敏感性降低,这在该药在中国获得批准之前就已存在。
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0075424. doi: 10.1128/aac.00754-24. Epub 2024 Oct 10.
3
Complete Genome Sequence of a Strain Carrying Novel Variant , Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023.2023年在意大利分离出的携带新型变体的菌株的全基因组序列,对头孢他啶/阿维巴坦和头孢地尔耐药,但对碳青霉烯类敏感
Pathogens. 2024 Jun 15;13(6):507. doi: 10.3390/pathogens13060507.
4
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.耐碳青霉烯类肺炎克雷伯菌感染治疗期间因质粒介导的突变导致头孢他啶-阿维巴坦耐药的出现
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02097-16. Print 2017 Mar.
5
Global molecular epidemiology of the incomplete CirA protein related to cefiderocol resistance in : a genome-based study.基于基因组的研究:与头孢地尔耐药性相关的不完整CirA蛋白的全球分子流行病学
Microbiol Spectr. 2025 May 6;13(5):e0141024. doi: 10.1128/spectrum.01410-24. Epub 2025 Mar 19.
6
Clinical and Molecular Description of a High-Copy IncQ1 KPC-2 Plasmid Harbored by the International ST15 Klebsiella pneumoniae Clone.国际ST15肺炎克雷伯菌克隆携带的高拷贝IncQ1型KPC-2质粒的临床与分子特征描述
mSphere. 2020 Oct 7;5(5):e00756-20. doi: 10.1128/mSphere.00756-20.
7
Emergence of cefiderocol resistance during therapy in NDM-5-producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations.在携带铁载体受体突变的产NDM-5肺炎克雷伯菌分离株治疗期间出现头孢地尔耐药性。
Int J Infect Dis. 2025 Feb;151:107321. doi: 10.1016/j.ijid.2024.107321. Epub 2024 Nov 30.
8
Effects of different carbapenemase and siderophore production on cefiderocol susceptibility in .不同碳青霉烯酶产生及铁载体生成对头孢地尔敏感性的影响
Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0101924. doi: 10.1128/aac.01019-24. Epub 2024 Oct 29.
9
Antimicrobial Resistance Caused by KPC-2 Encoded by Promiscuous Plasmids of the Klebsiella pneumoniae ST307 Strain.由肺炎克雷伯菌 ST307 株的多功能质粒编码的 KPC-2 引起的抗生素耐药性。
Ann Lab Med. 2021 Jan;41(1):86-94. doi: 10.3343/alm.2021.41.1.86. Epub 2020 Aug 25.
10
Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.尿路感染分离株中的肺炎克雷伯菌碳青霉烯酶(KPC)。
Arch Microbiol. 2021 May;203(4):1825-1831. doi: 10.1007/s00203-020-02161-x. Epub 2021 Jan 28.

引用本文的文献

1
Siderophores and beyond: A comprehensive review of iron acquisition in .铁载体及其他:关于……中铁获取的全面综述
Virulence. 2025 Dec;16(1):2550621. doi: 10.1080/21505594.2025.2550621. Epub 2025 Sep 3.
2
Spontaneous Emergence of Cefiderocol Resistance in KPC-163: Genomic and Transcriptomic Insights.KPC-163中头孢地尔耐药性的自发出现:基因组和转录组学见解
Antibiotics (Basel). 2025 Aug 15;14(8):832. doi: 10.3390/antibiotics14080832.
3
The Multifaceted Landscape of Healthcare-Associated Infections Caused by Carbapenem-Resistant .

本文引用的文献

1
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics.ESKAPE 病原体:抗微生物药物耐药性、流行病学、临床影响和治疗学。
Nat Rev Microbiol. 2024 Oct;22(10):598-616. doi: 10.1038/s41579-024-01054-w. Epub 2024 Jun 3.
2
Hybracter: enabling scalable, automated, complete and accurate bacterial genome assemblies.Hybracter:实现可扩展、自动化、完整和准确的细菌基因组组装。
Microb Genom. 2024 May;10(5). doi: 10.1099/mgen.0.001244.
3
Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy.
耐碳青霉烯类药物引起的医疗保健相关感染的多方面情况
Microorganisms. 2025 Apr 5;13(4):829. doi: 10.3390/microorganisms13040829.
4
From Clinical Trials to Real-World Experiences: Evidence About Cefiderocol Use and Potential Role in Empirical Therapy.从临床试验到真实世界经验:关于头孢地尔使用及在经验性治疗中潜在作用的证据
Infect Dis Ther. 2025 May;14(5):897-909. doi: 10.1007/s40121-025-01147-w. Epub 2025 Apr 9.
5
Outbreak of High-Risk Clone ST323 Resistant to Ceftazidime-Avibactam Due to Acquisition of and to Cefiderocol Due to Mutated Gene.因获得blaOXA-181基因而对头孢他啶-阿维巴坦耐药且因mcr-1基因变异而对头孢地尔耐药的高危克隆ST323暴发。
Antibiotics (Basel). 2025 Feb 21;14(3):223. doi: 10.3390/antibiotics14030223.
意大利产头孢他啶/阿维巴坦、美罗培南/比阿培南和头孢地尔洛治疗期间肺炎克雷伯菌 512 型序列的基因型演变。
Emerg Infect Dis. 2023 Nov;29(11):2266-2274. doi: 10.3201/eid2911.230921.
4
An NDM-Producing Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance.一株产NDM的临床分离株对头孢地尔、头孢他啶-阿维巴坦合剂及氨曲南耐药:迈向泛β-内酰胺耐药的又一步。
Open Forum Infect Dis. 2023 May 17;10(7):ofad276. doi: 10.1093/ofid/ofad276. eCollection 2023 Jul.
5
Fatty Acids Abolish Virulence by Inhibiting Its Master Regulator, VirF.脂肪酸通过抑制其主要调控因子 VirF 来消除毒力。
Microbiol Spectr. 2023 Jun 15;11(3):e0077823. doi: 10.1128/spectrum.00778-23. Epub 2023 May 4.
6
The acquisition of transferable extrachromosomal fec operon is associated with a cefiderocol MIC increase in Enterobacterales.可转移外染色体 fec 操纵子的获得与肠杆菌科头孢地尔可 MIC 增加有关。
J Antimicrob Chemother. 2022 Nov 28;77(12):3487-3495. doi: 10.1093/jac/dkac347.
7
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.耐头孢他啶-阿维巴坦的肺炎克雷伯菌碳青霉烯酶变异体:进化概述。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0044722. doi: 10.1128/aac.00447-22. Epub 2022 Aug 18.
8
Catecholate siderophore receptor CirA impacts cefiderocol susceptibility in Klebsiella pneumoniae.儿茶酚盐铁载体受体CirA影响肺炎克雷伯菌对头孢地尔的敏感性。
Int J Antimicrob Agents. 2022 Oct;60(4):106646. doi: 10.1016/j.ijantimicag.2022.106646. Epub 2022 Jul 31.
9
Ferric Citrate Uptake Is a Virulence Factor in Uropathogenic Escherichia coli.柠檬酸铁摄取是尿路致病性大肠杆菌的毒力因子。
mBio. 2022 Jun 28;13(3):e0103522. doi: 10.1128/mbio.01035-22. Epub 2022 May 12.
10
Different Conformations Revealed by NMR Underlie Resistance to Ceftazidime/Avibactam and Susceptibility to Meropenem and Imipenem among D179Y Variants of KPC β-Lactamase.D179Y 变异型 KPC 酶通过 NMR 揭示的不同构象导致对头孢他啶/阿维巴坦的耐药性和对美罗培南及亚胺培南的敏感性。
Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0212421. doi: 10.1128/aac.02124-21. Epub 2022 Mar 21.